SCHEMBL7098907

SCHEMBL7098907

CC(=N)Nc1cccc(C(=O)NNC(=O)CC(CC(=O)O)c2ccc(F)cc2)c1

nearest known ligand 0.67

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 17/20 0.67
ITGAV P06756 17/20 0.67
ITGA2B P08514 4/20 0.54
FNTA P49354 1/20 0.45
FNTB P49356 1/20 0.45
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7102231 0.90 ITGB3 (0.68) ITGB3ITGAVITGA2BFNTAFNTB
SCHEMBL7098481 0.90 ITGB3 (0.67) ITGB3ITGAVITGA2BHTTSMN1; SMN2
SCHEMBL7103918 0.90 ITGB3 (0.67) ITGB3ITGAVITGA2BFNTAFNTB
SCHEMBL7106602 0.90 ITGB3 (0.67) ITGB3ITGAVITGA2BFNTAFNTB
SCHEMBL7104776 0.88 ITGB3 (0.68) ITGB3ITGAVITGA2BFNTAFNTB
SCHEMBL7099691 0.86 ITGB3 (0.67) ITGB3ITGAVITGA2BHTTSMN1; SMN2
SCHEMBL13703191 0.82 ITGB3 (0.57) ITGB3ITGAVITGA2BFNTAFNTB
SCHEMBL7105696 0.82 ITGB3 (0.51) ITGB3ITGAVITGA2BSMN1; SMN2KMT2A
SCHEMBL7099298 0.81 ITGB3 (0.66) ITGB3ITGAVITGA2BHTTSMN1; SMN2
SCHEMBL7105309 0.80 ITGB3 (0.68) ITGB3ITGAVITGA2BFNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6649613-B1 Integrin inhibitors MERCK PATENT GMBH (DE) 2003-11-18 US disclosed
EP-1194401-B1 DIACYLHYDRAZINE DERIVATIVES MERCK PATENT GMBH (DE) 2003-09-10 EP disclosed
EP-1194401-A1 DIACYLHYDRAZINE DERIVATIVES MERCK PATENT GmbH (DE) 2002-04-10 EP disclosed
WO-2001005753-A1 DIACYLHYDRAZINE DERIVATIVES MERCK PATENT GMBH (DE) 2001-01-25 WO disclosed